FASENRA Pen® (benralizumab)

FASENRA Pen gives you the option to self-administer after proper training and your healthcare provider's approval.

The FASENRA Pen® (benralizumab) is a single-use, disposable delivery system for administering Fasenra, an FDA-approved, add-on maintenance treatment created by AstraZeneca for patients 12 and older with severe eosinophilic asthma.

Add-on injection for people 12 and up with severe eosinophilic asthma. Nor for sudden breathing problems or for other problems caused by eosinophils. May cause allergic reactions. Get help right away if you have swelling of mouth, face, tongue, or trouble breathing. Don’t stop your asthma treatments. Tell your doctor if asthma worsens or you have a parasitic infection. May cause headache and sore throat.

Learn More About Fasenra
Ease of Use Program

Products Proven to Make Life Easier

The Arthritis Foundation's Ease of Use Certification Program recognizes products proven to make life easier for people who have arthritis and other physical limitations. Independently tested by experts and evaluated by people with arthritis, Ease of Use products are easy to use for everyone.

Learn More About the Ease of Use Program
Products Proven to Make Life Easier